SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing intense volatility as traders debate its role as a core payment rail for AI agents and the potential impact of legislative developments like the Clarity Act. Community sentiment is deeply divided, with some investors aggressively accumulating on dips in anticipation of a breakout, while others remain skeptical due to persistent resistance levels and macroeconomic headwinds.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

JNUG is trending as investors weigh aggressive monetary and fiscal policies, including expectations for significant interest rate cuts and expanded liquidity measures, against an environment of heightened geopolitical conflict and supply chain disruptions. Community discourse is focused on the metal's performance as a hedge against inflation and systemic economic fragility, with active debate regarding potential volatility and the sustainability of recent price trends.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending as investors capitalize on surging demand for autonomous drones and next-generation military technology, supported by bullish institutional interest and potential government funding. The community is actively debating the stock's long-term growth as part of the broader defense sector rotation, with many highlighting the strength of its massive production backlog and recent contracts as key catalysts for sustained upside potential.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to the FDA's decision to convene an advisory committee on July 29 to review the BLA for its DMD therapy, deramiocel, ahead of the August PDUFA date. While the community is actively debating the implications of this meetingwith many seeing it as a standard regulatory step for a first-in-class therapy and others expressing concerns over potential label restrictions or procedural scrutinyinvestors remain highly focused on the strength of the clinical trial data and the company's pending litigation over distribution rights.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF (UVXY) is trending as traders debate whether current market stability is a genuine reflection of strength or a 'manipulated' calm masking underlying geopolitical and economic risks. The community is deeply divided between those viewing the instrument as a long-term 'scam' due to its structural decay and those aggressively positioning for a potential volatility spike driven by war rhetoric, inflation concerns, and bubble risks.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors respond to positive updates regarding the advancement of its clinical pipeline and ongoing BLA preparations for its lead program, CAN-2409. The community is actively debating the company's valuation potential against current market capitalization, while focusing on the significance of upcoming regulatory catalysts and institutional positioning.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is currently generating significant community buzz following news of its partnership with Lenovo to deploy 200,000 autonomous vehicles globally by 2030 and an aggressive stock buyback campaign. Investors are closely scrutinizing whether these expansion efforts and factory-integrated ADAS wins can effectively translate into sustainable revenue and profitability amidst ongoing volatility in Chinese ADRs.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending as investors debate whether the current price represents a generational buying opportunity or a deeper correction, with many retail participants citing strong brand loyalty and the recent Rhode acquisition as key growth catalysts. Community discussion remains polarized, with some bulls aggressively accumulating shares based on fundamental strength and valuation metrics, while bears point to ongoing technical pressure and broader sector volatility.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF ($GDX) is trending as gold miners face technical support tests and a complex macro environment defined by shifting interest rate expectations and persistent inflation concerns. The community is actively debating the reliability of mining stocks as a leverage play on gold prices, while analyzing Elliott Wave structures and potential entry points amidst ongoing geopolitical instability in the Middle East.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro is gaining significant traction in the semiconductor sector as investors highlight its ultra-low-power edge AI chips and potential for growth in the robotics and physical AI markets. The community is actively discussing the stock's long-term potential, including speculation around partnerships and upcoming industry events, while maintaining a humorous and highly engaged social sentiment.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

Equity

Wall Street sees bigger upside in VKTX, with Koyfin’s average target implying 120% upside versus 99% for BCRX.

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

Multiple analysts reiterated optimism on CMPS stock after the company announced 26-week data from its second late-stage trial of COMP360 in treatment-resistant depression.


AGIO Stock Hits Over 7-Month Highs – FDA Catalyst, ‘Seasonally Strong’ Q2 Earnings Estimate Drive Optimism

Agios said the U.S. Food and Drug Administration granted Priority Review to its supplemental new drug application for Mitapivat in sickle cell disease.

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns 

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 


ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

Abivax said the findings strengthen the overall case for obefazimod and reinforce its favorable benefit-risk profile.


Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know

Larimar submitted the module of a rolling biologics license application to the U.S. Food and Drug Administration for the accelerated approval of nomlabofusp for Friedreich’s ataxia.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's 

IBB, Novartis, Pfizer and Eli Lilly's have been highlighted in this Investment Ideas article.

Biotech's Silent Resurgence (5-Year Base Breakout)

The biotech sector's fundamentals are shifting rapidly-and the smartest money on Wall Street is already quietly rotating into the sector. 

DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know

Definium said it will host a webcast on Tuesday morning to discuss results from Emerge, a Phase 3 study evaluating DT120 ODT in adults with Major Depressive Disorder.

iShares Trust - iShares Biotechnology ETF

Neutral Sentiment

< 1 yr

1 - 3 yrs

3 - 10 yrs

10+ yrs

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&P Global

Feed

News

Sentiment

Fundamentals

Info

IBBiShares Biotechnology ETF

Fundamentals

Latest IBB News